ALK & DESIGN
"ALK & DESIGN" is a figurative mark owned by Alk-Abelló A/S, filed at the CIPO on November 21, 2013. It is registered and covers classes 1, 5, 10, 42 and 44.
- Status
- Registered
- Since February 2, 2016
- Filed
- November 21, 2013
- Registered
- February 2, 2016
- Expires
- February 2, 2031
- Application no.
- 1653812
- Registration no.
- TMA927863
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Figurative mark
- 5 classes
Who owns ALK & DESIGN
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Alk-Abelló A/S
Denmark
Representative
Deeth Williams Wall LLP
Deeth Williams Wall LLP
What the mark covers
The products and services ALK & DESIGN is filed for, grouped by Nice class.
Diagnostic preparations for scientific or research purposes, namely, diagnostic preparations for the treatment, monitoring and diagnosing of allergies, asthma, rhinitis and respiratory diseases.; Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma and respiratory allergic diseases.; Diagnostic preparations for medical purposes, namely, diagnostic reagents and diagnostic testing materials for diagnosing, preventing and treating allergies, asthma, rhinitis and respiratory diseases.; Pharmaceutical preparations in the form of injectable pharmaceuticals, namely, injectable adrenaline for treatment of anaphylactic reactions and injectable preparations for treatment and prevention of allergies, asthma, rhinitis and respiratory diseases.; Diagnostic devices, apparatus and instruments for medical use, namely, diagnostic test kits for diagnosing, preventing and treating allergies, asthma, rhinitis and respiratory diseases; inhalers, namely inhalers for therapeutic use; medical devices, namely, injectors for treatment of anaphylactic reactions; hypodermic injectors and holders for hypodermic injectors; parts and fittings for all the aforesaid goods.
Diagnostic preparations for scientific or research purposes, namely, diagnostic preparations for the treatment, monitoring and diagnosing of allergies, asthma, rhinitis and respiratory diseases.; Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma and respiratory allergic diseases.; Diagnostic preparations for medical purposes, namely, diagnostic reagents and diagnostic testing materials for diagnosing, preventing and treating allergies, asthma, rhinitis and respiratory diseases.; Pharmaceutical preparations in the form of injectable pharmaceuticals, namely, injectable adrenaline for treatment of anaphylactic reactions and injectable preparations for treatment and prevention of allergies, asthma, rhinitis and respiratory diseases.; Diagnostic devices, apparatus and instruments for medical use, namely, diagnostic test kits for diagnosing, preventing and treating allergies, asthma, rhinitis and respiratory diseases; inhalers, namely inhalers for therapeutic use; medical devices, namely, injectors for treatment of anaphylactic reactions; hypodermic injectors and holders for hypodermic injectors; parts and fittings for all the aforesaid goods.
Diagnostic preparations for scientific or research purposes, namely, diagnostic preparations for the treatment, monitoring and diagnosing of allergies, asthma, rhinitis and respiratory diseases.; Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma and respiratory allergic diseases.; Diagnostic preparations for medical purposes, namely, diagnostic reagents and diagnostic testing materials for diagnosing, preventing and treating allergies, asthma, rhinitis and respiratory diseases.; Pharmaceutical preparations in the form of injectable pharmaceuticals, namely, injectable adrenaline for treatment of anaphylactic reactions and injectable preparations for treatment and prevention of allergies, asthma, rhinitis and respiratory diseases.; Diagnostic devices, apparatus and instruments for medical use, namely, diagnostic test kits for diagnosing, preventing and treating allergies, asthma, rhinitis and respiratory diseases; inhalers, namely inhalers for therapeutic use; medical devices, namely, injectors for treatment of anaphylactic reactions; hypodermic injectors and holders for hypodermic injectors; parts and fittings for all the aforesaid goods.
Medical and pharmacological research services and design relating to pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases.; Medical laboratory services, clinical trials.; Medical consulting services, namely, providing counselling and medical information regarding immunotherapy, allergy, asthma, allergic rhinitis and allergic asthma, respiratory allergic diseases and anaphylactic reactions.; Providing patient support relating to immunotherapy and the diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.; Providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.
Medical and pharmacological research services and design relating to pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases.; Medical laboratory services, clinical trials.; Medical consulting services, namely, providing counselling and medical information regarding immunotherapy, allergy, asthma, allergic rhinitis and allergic asthma, respiratory allergic diseases and anaphylactic reactions.; Providing patient support relating to immunotherapy and the diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.; Providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Allowance Notice Sent
- Allowed
- Advertised; Vol.62 Issue 3161
- Approved; APPROVED BY PROGRAM EX200M1
- Approval Notice Sent
- Examiner's First Report
- Search Recorded
- Formalized
- Created
1 earlier step on the official record.
About ALK & DESIGN
Who owns the trademark "ALK & DESIGN"?
The CIPO trademark "ALK & DESIGN" (application 1653812) is owned by Alk-Abelló A/S.
What is the status of "ALK & DESIGN"?
Its status at the CIPO is: registered.
When was "ALK & DESIGN" registered?
It was registered on February 2, 2016 and is due to expire on February 2, 2031.
Get this data via the API
Everything on this page comes from the Signa API. Pull ALK & DESIGN and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb30-1306-718d-ad6b-030be48f62b9
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb30-1306-718d-ad6b-030be48f62b9",
"object": "trademark",
"mark_text": "ALK & DESIGN",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1653812",
"filing_date": "2013-11-21",
"nice_classes": [
1,
5,
10,
42,
44
],
"owners": [
{
"name": "ALK-ABELLÓ A/S",
"entity_id": "ent_019eb6f7-d7a6-7420-874f-900c24eb0227"
}
]
}